drugset / Trial / NCT01280591

Evaluate Analgesic/Sedative Efficacy of Naproxen Sodium and Diphenhydramine in Patients With Postsurgical Dental Pain

NCT01280591

Phase 3 Completed 712 enrolled Bayer
RandomizedParallel-groupTriple-blindTreatment

Summary

The objective of the study is to evaluate the efficacy and safety of a single oral dose of two dose combinations of naproxen sodium and diphenhydramine (DPH) to demonstrate that naproxen sodium/DPH combination provides added clinical benefit to sleep improvement than either single ingredient alone in subjects with post-surgical dental pain and phase advanced sleep.

Timeline

Start
2010-10
Primary completion
2011-01
Completion
2011-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Diphenhydramine Unknown 50 mg Oral
Comparator Naproxen Small molecule 220 mg Oral
Comparator Naproxen Small molecule 440 mg Oral

Indications

No indication recorded.